Skip to product information
1 of 1

Elabscience

SKU:PKSH033908

Recombinant Human T-cell Surface Protein Tactile/CD96(C-Fc)

Recombinant Human T-cell Surface Protein Tactile/CD96(C-Fc)

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant Human T-Cell Surface Protein TACTILE/CD96(C-FC), a cutting-edge product designed to revolutionize the field of immunology. This innovative protein, derived from human T-cells, serves as a crucial component in various cellular processes, particularly in the regulation of immune responses.

Crafted through advanced recombinant technology, this T-cell surface protein exhibits exceptional purity and stability, ensuring optimal performance in a wide range of applications. Its high affinity for ligand binding enables precise interactions with its cellular counterparts, facilitating the transmission of crucial signals within the immune system.

The Recombinant Human T-Cell Surface Protein TACTILE/CD96(C-FC) boasts remarkable versatility, making it an invaluable tool for researchers and scientists alike. Its utilization spans across diverse areas, including but not limited to immunotherapy, cancer research, and autoimmune disease studies. By harnessing the potential of this protein, researchers can gain deeper insights into the intricate mechanisms governing T-cell function and immune regulation.

Furthermore, this product's exceptional quality is underscored by its rigorous manufacturing process, adhering to stringent quality control measures. Each batch undergoes meticulous testing to ensure consistency, reliability, and reproducibility, guaranteeing accurate and dependable results in every experiment.

In summary, the Recombinant Human T-Cell Surface Protein TACTILE/CD96(C-FC) represents a breakthrough in the field of immunology, offering researchers an indispensable tool to unravel the complexities of T-cell biology. With its unrivaled purity, stability, and versatility, this product is poised to drive advancements in immunological research, ultimately contributing to the development of novel therapeutic strategies and improved patient outcomes.
View full details